Aytu BioScience, Inc. is a specialty pharmaceutical company. The Company markets a portfolio of prescription products addressing primary care and pediatric markets. The primary care portfolio includes Natesto, the nasal formulation of testosterone for men with hypogonadism, ZolpiMist, the oral spray prescription sleep aid, and Tuzistra XR, the 12-hour codeine-based antitussive syrup. The pediatric portfolio includes AcipHex Sprinkle, a granule formulation of rabeprazole sodium, a commonly prescribed proton pump inhibitor; Cefaclor, a second-generation cephalosporin antibiotic suspension; Karbinal ER, an extended-release carbinoxamine suspension indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various for infants and children with fluoride deficiency.